Matches in Wikidata for { <http://www.wikidata.org/entity/Q92421127> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q92421127 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q92421127 description "scientific article published on 14 March 2019" @default.
- Q92421127 description "wetenschappelijk artikel" @default.
- Q92421127 description "наукова стаття, опублікована 14 березня 2019" @default.
- Q92421127 name "The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care" @default.
- Q92421127 name "The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care" @default.
- Q92421127 type Item @default.
- Q92421127 label "The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care" @default.
- Q92421127 label "The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care" @default.
- Q92421127 prefLabel "The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care" @default.
- Q92421127 prefLabel "The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care" @default.
- Q92421127 P1433 Q92421127-3C3BEE34-A633-40F8-9467-5083C03AC04F @default.
- Q92421127 P1476 Q92421127-1E8E0E15-7936-4FAC-A613-8154D26A5FDE @default.
- Q92421127 P2093 Q92421127-1F2166C0-1EA4-4418-9C96-C95A2501D1F8 @default.
- Q92421127 P2093 Q92421127-434DB464-14AD-4F4C-94EB-8C8583ADC537 @default.
- Q92421127 P2093 Q92421127-4A88AACB-42AF-4E86-B3F6-64C66F39DB0B @default.
- Q92421127 P2093 Q92421127-5187CFC7-5A76-4E8D-B22D-0AA8D97BA451 @default.
- Q92421127 P2093 Q92421127-8E5DFCF8-381D-44C0-961E-B2689A283E04 @default.
- Q92421127 P2093 Q92421127-A5B15E81-5CEA-475B-AAD5-C20053EC5EA1 @default.
- Q92421127 P2093 Q92421127-AFEE1272-FBFE-4850-8B32-03DDCA75B264 @default.
- Q92421127 P2093 Q92421127-BC82BF0F-9CF3-429E-B339-7B76192EA674 @default.
- Q92421127 P2093 Q92421127-BDC8DFE5-F26B-4A4E-B304-73530A0527FB @default.
- Q92421127 P2093 Q92421127-C14267A0-50E7-48B6-AE74-7911D14054B9 @default.
- Q92421127 P2093 Q92421127-D6268143-4496-41CA-8FB2-A35F4AF0880D @default.
- Q92421127 P2093 Q92421127-D750BEDB-B4CD-4DE8-8786-024ACDDDF67A @default.
- Q92421127 P304 Q92421127-E46A09B1-DCFE-43B0-BE84-57E44ADD0AAC @default.
- Q92421127 P31 Q92421127-972CF89D-586C-4D21-A76A-A3CF7B4351D3 @default.
- Q92421127 P356 Q92421127-EFFDCDB1-D599-4F4F-A5A4-A0287AB834D2 @default.
- Q92421127 P478 Q92421127-81E9659B-3D99-4912-AB73-0A752B88C0B5 @default.
- Q92421127 P577 Q92421127-E90722C8-4A43-4D07-9B72-15B47BCC6251 @default.
- Q92421127 P698 Q92421127-60EEEFDD-07BB-4449-84B8-4876A0762493 @default.
- Q92421127 P921 Q92421127-BCE47773-FD3B-475F-9A42-926D7F29EE8B @default.
- Q92421127 P921 Q92421127-C1F16F24-02F6-4171-9708-B016268FD079 @default.
- Q92421127 P356 J.DIABRES.2019.03.015 @default.
- Q92421127 P698 30880094 @default.
- Q92421127 P1433 Q15750054 @default.
- Q92421127 P1476 "The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care" @default.
- Q92421127 P2093 "Alaaeldin Bashier" @default.
- Q92421127 P2093 "Azza Khalifa" @default.
- Q92421127 P2093 "Elamin Abdelgadir" @default.
- Q92421127 P2093 "Fatheya Alawadi" @default.
- Q92421127 P2093 "Fatima Al Sayyah" @default.
- Q92421127 P2093 "Fauzia Rashid" @default.
- Q92421127 P2093 "Fawzi Bachet" @default.
- Q92421127 P2093 "Khadija Abdallah" @default.
- Q92421127 P2093 "Maryam Al Saeed" @default.
- Q92421127 P2093 "Mohamed Hassanein" @default.
- Q92421127 P2093 "Mohammed Elsayed" @default.
- Q92421127 P2093 "Sona Abuelkheir" @default.
- Q92421127 P304 "305-312" @default.
- Q92421127 P31 Q13442814 @default.
- Q92421127 P356 "10.1016/J.DIABRES.2019.03.015" @default.
- Q92421127 P478 "151" @default.
- Q92421127 P577 "2019-03-14T00:00:00Z" @default.
- Q92421127 P698 "30880094" @default.
- Q92421127 P921 Q736715 @default.
- Q92421127 P921 Q95987978 @default.